Avid Bioservices Inc (CDMO)

[bfiest]

When they get the work it will be very late to expand. It’s a robust market and covid19 has created the perfect storm for CDMO’s. The focus on bringing drug manufacturing back to the US can only increase demand. Yes there is risk in expansion without financial assistance. And yes it will likely cost short term gains if they have to incur the cost without help.

But that’s why these guys are paid handily. They have to proceed now like they are going to be serious players in the future. That’s called business intuition and confidence both of which are measured in results. Sitting on their hands in a market where capacity is limited and highly valued is not the approach that delivers big results. I look forward to hearing their strategy concerning expansion at the upcoming shareholders meeting if not sooner. My vote — proceed with confidence and a do whatever it takes attitude.